VM
Venus Medtech (Hangzhou) Inc. - B - H Shares Stock: price and insider trades · Hong Kong
Venus Medtech (Hangzhou) Inc. - B - H Shares: what insiders have been doing
Venus Medtech (Hangzhou) Inc. - B - H Shares has a thin disclosure history in our data (latest filing: 7 August 2026). New filings will appear here as soon as they are published. This summary is built from HKEX disclosures alone and does not predict where the share price will go.
Insider Decl.
1
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Fundamental score
Ranked 23,228 of 26,897 companies
25.4
score / 100
Value2
Quality49
FCF yld-74%
Earn yld-90%
EV/EBITDA·
ROE-26%
Gross mgn69%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
HK$1.05
Analyst consensus
1 analystsHK$4.62Target HK$4.62(+342%)HK$4.62
Income statement
RevenueHK$306.8M
Gross profitHK$211.8M69% margin
EBITDA-HK$289.7M-94% margin
Net income-HK$407.7M-181.9% margin
Valuation
PER (forward)17.1x
P/Book0.3x
Beta1.11
Balance sheet & cash
Market capHK$457.6M
Total debtHK$62.1M
Free Cash Flow-HK$332.1M
Debt / Equity13%
Profitability & ownership
ROE-25.8%
ROA-8.9%
% insiders17.0%
% institutions18.7%
Last declaration on 7 August 2026
About Venus Medtech (Hangzhou) Inc. - B - H Shares
Venus Medtech (Hangzhou) Inc. is a company focused on the development of medical devices, particularly products for cardiology. It is listed on the B shares market in Hong Kong.
